Streetbeat News

Price Targets

AXSM

Axsome Therapeutics (NASDAQ:AXSM) shares are trading higher following a recent corporate presentation where the company provided peak sales estimates for drugs in its portfolio. Mizuho analyst Graig Suvannavejh reiterated a Buy rating and maintained a $95 price target, while Morgan Stanley analyst Vikram Purohit maintained an Equal-Weight rating and raised the price target from $87 to $90.

Portfolio Pulse from Ryan Gustafson

June 14, 2023 | 7:47 pm

DECK

Raymond James initiated coverage on Deckers Outdoor Corporation (DECK) with an Outperform rating and a $565 price target, leading to higher trading of DECK shares.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 7:39 pm

AMAM

AZN

NVS

PFE

SGEN

B Riley Securities initiates coverage on Ambrx Biopharma (AMAM) with a 'Buy' rating and a price target of $26 per share. The analyst highlights excitement around antibody-drug conjugates (ADCs) and recommends investors build positions ahead of clinical updates for ARX517 and ARX788.

Portfolio Pulse from Vandana Singh

June 14, 2023 | 7:05 pm

WDAY

Oppenheimer analyst Brian Schwartz reiterated an Outperform rating on Workday, Inc. (NASDAQ:WDAY) with a price target of $240. The analyst believes Workday is well-positioned to benefit from strength in its core markets, increasing sales capacity investments, and AI functionality.

Portfolio Pulse from Nabaparna Bhattacharya

June 14, 2023 | 7:04 pm

VRDN

Over the past 3 months, 11 analysts have published their opinion on Viridian Therapeutics (NASDAQ:VRDN) stock, with 4 bullish and 7 somewhat bullish ratings. The average 12-month price target is $46.0, with a high of $51.00 and a low of $40.00.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:02 pm

RENT

JMP Securities analyst Andrew Boone reiterated a Market Outperform rating on Rent the Runway Inc (NASDAQ:RENT) with a price target of $6. The company is focused on improving customer onboarding and inventory depth, and plans to introduce AI-powered search. RTR expects active subscriber growth to accelerate to +25% Y/Y by year end.

Portfolio Pulse from Shivani Kumaresan

June 14, 2023 | 7:01 pm

GHI

In the last 3 months, 4 analysts have provided 12-month price targets for Greystone Housing Impact (NYSE:GHI), with an average price target of $19.75, a 2.85% decrease from the previous average of $20.33.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 7:00 pm

CRM

Oppenheimer analyst Brian Schwartz reiterated an Outperform rating on Salesforce (NYSE:CRM) with a price target of $235. He believes the company is well positioned to benefit from vendor consolidation trends, AI product prioritization, and improving business efficiency. Salesforce is also poised to gain from margin growth, increased multi-cloud adoption, and success with verticalized solutions.

Portfolio Pulse from Nabaparna Bhattacharya

June 14, 2023 | 6:58 pm

VRNT

Needham analyst Ryan MacDonald reiterated a Buy rating on Verint Systems Inc. (NASDAQ:VRNT) with a price target of $50, citing the company's AI-driven CX Automation initiatives. The analyst believes these bots will drive incremental efficiency and curb rising labor costs, and expects Verint's customer engagement business to support a near 30% EBITDA margin.

Portfolio Pulse from Nabaparna Bhattacharya

June 14, 2023 | 6:03 pm

GM

Morgan Stanley analyst Adam Jonas reiterated an Overweight rating on General Motors (NYSE:GM) with a price target of $38, highlighting the company's AI capabilities and potential in autonomous vehicles. Despite the market's focus on near-term profitability, Jonas believes GM's Cruise unit and in-house L2+ ADAS capabilities in Super Cruise and Ultra Cruise hold significant value.

Portfolio Pulse from Shivani Kumaresan

June 14, 2023 | 5:46 pm